|
|
|
Insider
Information: |
Kennedy Giulia C |
Relationship: |
Chief Scientific & Med... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
65,970 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,404,501 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
65,970 |
|
|
Total
Value |
$1,404,501 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Veracyte, Inc. |
VCYT |
Chief Scientific & Med... |
2022-12-06 |
65,970 |
2019-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
80,764 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2021-09-07 |
4 |
AS |
$50.52 |
$633,408 |
D/D |
(12,531) |
50,975 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2021-09-07 |
4 |
OE |
$5.98 |
$210,154 |
D/D |
12,531 |
63,506 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-12-04 |
4 |
OE |
$5.98 |
$150,209 |
D/D |
13,468 |
92,327 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-12-04 |
4 |
AS |
$55.78 |
$797,156 |
D/D |
(14,015) |
78,312 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-09-03 |
4 |
AS |
$25.20 |
$380,656 |
D/D |
(15,031) |
48,037 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-09-03 |
4 |
OE |
$5.43 |
$107,100 |
D/D |
15,031 |
63,068 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-12-03 |
4 |
OE |
$5.43 |
$107,103 |
D/D |
15,032 |
62,189 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-03-03 |
4 |
OE |
$5.43 |
$107,111 |
D/D |
15,033 |
114,155 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-12-03 |
4 |
AS |
$26.47 |
$405,663 |
D/D |
(15,327) |
46,862 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-07-13 |
4 |
AS |
$28.82 |
$496,478 |
D/D |
(16,738) |
80,487 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-07-13 |
4 |
OE |
$5.98 |
$218,373 |
D/D |
16,738 |
97,225 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-03-04 |
4 |
OE |
$5.98 |
$105,398 |
D/D |
17,625 |
66,249 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-03-04 |
4 |
S |
$20.24 |
$356,709 |
D/D |
(17,625) |
48,624 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-07-31 |
4 |
AS |
$35.33 |
$706,694 |
D/D |
(20,000) |
80,487 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-07-31 |
4 |
OE |
$20.21 |
$404,200 |
D/D |
20,000 |
100,487 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2022-03-04 |
4 |
AS |
$24.91 |
$577,783 |
D/D |
(23,003) |
61,391 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2022-03-04 |
4/A |
AS |
$24.91 |
$578,535 |
D/D |
(23,033) |
61,361 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-08-12 |
4 |
OE |
$5.43 |
$232,095 |
D/D |
27,962 |
76,294 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-08-12 |
4 |
AS |
$25.38 |
$717,095 |
D/D |
(28,257) |
48,037 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2021-03-04 |
4 |
OE |
$5.98 |
$582,299 |
D/D |
30,970 |
105,739 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-12-05 |
4 |
OE |
$14.34 |
$470,395 |
D/D |
32,803 |
79,665 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-12-05 |
4 |
AS |
$29.39 |
$964,142 |
D/D |
(32,803) |
46,862 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2020-03-03 |
4 |
AS |
$25.35 |
$834,798 |
D/D |
(32,881) |
81,274 |
0 |
% |
|
VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
|
2019-02-28 |
4 |
OE |
$5.43 |
$298,755 |
D/D |
37,375 |
86,775 |
0 |
- |
|
80 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|